rs777686211
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001384732.1(CPLANE1):c.1819delT(p.Tyr607ThrfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.000178 in 1,539,856 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001384732.1 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPLANE1 | NM_001384732.1 | c.1819delT | p.Tyr607ThrfsTer6 | frameshift_variant | Exon 12 of 53 | ENST00000651892.2 | NP_001371661.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPLANE1 | ENST00000651892.2 | c.1819delT | p.Tyr607ThrfsTer6 | frameshift_variant | Exon 12 of 53 | NM_001384732.1 | ENSP00000498265.2 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152060Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000161 AC: 23AN: 142536Hom.: 0 AF XY: 0.000226 AC XY: 17AN XY: 75282
GnomAD4 exome AF: 0.000179 AC: 248AN: 1387796Hom.: 0 Cov.: 32 AF XY: 0.000196 AC XY: 134AN XY: 683914
GnomAD4 genome AF: 0.000171 AC: 26AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74304
ClinVar
Submissions by phenotype
Joubert syndrome 17 Pathogenic:6
- -
PVS1, PM2, PP3, PP5 -
- -
- -
This is a null variant in a gene where loss-of-function is a known mechnism of disease (PVS1_very strong). It is also found in extremely low frequency in gnomAD population databases (PM2_supporting). The variant was found in compound heterozygous state with NM_001384732.1:c.8633-4_8633-3del. -
This variant was identified as compound heterozygous. -
not provided Pathogenic:6
- -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28125082, 34008892, 26092869, 34313030, Shelby[2022]casereport) -
This sequence change creates a premature translational stop signal (p.Tyr607Thrfs*6) in the CPLANE1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CPLANE1 are known to be pathogenic (PMID: 24178751, 26092869). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Joubert syndrome (PMID: 26092869, 28125082). ClinVar contains an entry for this variant (Variation ID: 217590). For these reasons, this variant has been classified as Pathogenic. -
- -
CPLANE1: PVS1, PM2, PM3 -
- -
Orofaciodigital syndrome type 6;C3553264:Joubert syndrome 17 Pathogenic:2
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1819delT (p.Y607Tfs*6) alteration, located in exon 12 (coding exon 11) of the C5orf42 gene, consists of a deletion of one nucleotide at position 1819, causing a translational frameshift with a predicted alternate stop codon after 6 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration has been reported in the compound heterozygous state with a second C5orf42 alteration in a patient with Joubert syndrome (Bachmann-Gagescu, 2015). Based on the available evidence, this alteration is classified as pathogenic. -
Nephronophthisis Pathogenic:1
This patient is heterozygous for a likely pathogenic variant, c.1819del, in the C5orf42 gene. c.1819del (dbSNP: rs777686211) has been reported in the ExAC database (http://exac.broadinstitute.org/) with a low allele frequency of 0.024% (5/20526 alleles) and has also been reported as a compound heterozygous variant in a patient with Joubert syndrome (Bachmann-Gagescu et al. J.Med.Genet 2015; 52:514-522). This frameshifting variant is predicted to create a premature stop codon (p.Tyr607Thrfs*6) and may result in a null allele due to nonsense-mediated mRNA decay. This variant is considered to be a likely pathogenic according to the ACMG guidelines. -
Jaundice;C0557874:Global developmental delay Pathogenic:1
- -
CPLANE1-related disorder Pathogenic:1
The CPLANE1 c.1819delT variant is predicted to result in a frameshift and premature protein termination (p.Tyr607Thrfs*6). This variant has previously been reported in the compound heterozygous state in individuals with Joubert syndrome (Bachmann-Gagescu et al. 2015. PubMed ID: 26092869; Table 1, Vilboux T et al 2017. PubMed ID: 28125082). This variant is reported in 0.024% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CPLANE1 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Orofaciodigital syndrome type 6 Pathogenic:1
This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at